Clinical guideline developed by the American Heart Association and the American College of Cardiology.

Recent developments of interest in cardiovascular medicine ...

Acquisition includes HS235, a potentially best-in-class activin signalling inhibitor in clinical development for treatment of cardiopulmonary diseases HS235 offers potential to treat pulmonary ...

A new BMJ study found ChatGPT missed the urgency in 40% of genuine medical emergencies — but the real story isn't about the ...

In addition to affecting your sleep, obstructive sleep apnea (OSA) poses risks to your heart, metabolic health, and brain function if untreated.

Approval in adults and children aged 6 years and older supported by Phase 3 trial demonstrating Dupixent significantly reduced nasal signs and ...

Falls get attention, but cardiac, respiratory, and neurological events drive many medical alert activations. Learn what the ...

In 2026/27, investment in the GP contract will increase by £485 million, bringing the combined total estimated contract value to £13,863 million. This provides a 3.6% cash growth or 1.4% real terms ...

Doctors say that identifying the right patients will be critical to the future of the field. Only time will tell, according to trialists.

Sanofi and Regeneron’s Dupixent approved in the US as the first and only medicine for allergic fungal rhinosinusitisApproval in adults and ...

Elastic parametric response mapping (ePRM), a CT-based severity scoring system for regional lung volumes, can monitor COPD progression.